Showing 2181-2190 of 20409 results for "".
IUD Reduces Blood Loss by 90% in Patients with Heavy Menstrual Bleeding
https://reachmd.com/programs/advances-in-womens-health/iud-reduces-blood-loss-by-90-in-patients-with-heavy-menstrual-bleeding/15366/The use of levonorgestrel 52-mg IUD greatly reduced blood loss in patients with heavy menstrual bleeding, according to research presented at ACOG.Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
https://reachmd.com/programs/Audioabstracts/journal-cystic-fibrosis-efficacy-safety-levofloxacin-inhalation-solution-apt-1026/8217/A study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients.Understanding the Role of the Complement Pathways in IgAN
https://reachmd.com/programs/clinicians-roundtable/understanding-the-role-of-the-complement-pathways-in-igan/14911/Explore the two pathways that are key to the pathophysiology of IgA nephropathy and how they can impact the treatment of this rare disease.Fecal Transplants: The Future of IBD Therapy?
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/fecal-transplants-the-future-ibd-therapy/9609/Fecal transplants: the "inside poop" on an emerging IBD therapyImpact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations
https://reachmd.com/programs/Audioabstracts/impact-specialized-inpatient-ibd-care-outcomes-ibd-hospitalizations/8408/A look into the implementation of specialized inpatient IBD care for modifying short-term and long-term clinical outcomes for hospitalized patients.IL-31’s Role in Atopic Dermatitis and Prurigo Nodularis: Neuroimmune Insights
https://reachmd.com/programs/dermconsult/il-31-neuroimmune-insights-dermatitis-prurigo/51037/What if IL-31 is more than just the “itch cytokine”? Joining Dr. Raj Chovatiya to help answer that question and explore IL-31’s expanding role in inflammatory skin disease is Dr. Nicholas Mollanazar. Together, they examine how IL-31 bridges immune signaling, sensory nerve activation, and skin barrieCOVID-19 Vaccine Strategy: Understanding Broader Impacts
https://reachmd.com/programs/clinicians-roundtable/covid-vaccine-strategy-broad-impacts/48854/Effective vaccine guidance requires more than evaluating individual-level outcomes—it demands a comprehensive understanding of population dynamics, economic burden, and societal impact. Learn more with Dr. Darilyn Moyer, Executive Vice President and Chief Executive Officer of the American College ofAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
https://reachmd.com/programs/spotlight-subcutaneous--cancer-immunotherapy/an-analysis-of-subcutaneous-versus-intravenous-atezolizumab-in-nsclc/32992/How does subcutaneous atezolizumab compare to intravenous? Here’s what a clinical trial determined after evaluating the two approaches side by side.Timing Considerations for Skin Testing Following Food-Induced Anaphylaxis
https://reachmd.com/programs/frontlines-food-allergies/timing-considerations-for-skin-testing-following-food-induced-anaphylaxis/26313/When’s the best time to conduct skin testing after food-induced anaphylaxis? Explore the answer based on findings from a recent study.Mind-Body Therapies Result in Greater Improvement of Chronic Low Back Pain
https://reachmd.com/programs/the-jama-report/mind-body-therapies-result-greater-improvement-chronic-low-back-pain/8034/[Read the Article] Low back pain is a leading cause of disability in the United States. A new study shows that among adults with chronic back pain, both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) resulted in meaningful improvement in back pain compared to tradit